Shareholding disclosure

Basilea Pharmaceutica AG

Declared position

32.92%

Threshold

Crossed downwards

Timeline

Published

05.03.2021

Transaction

01.03.2021

Voting rights breakdown

Voting rights acquired8.72%

Voting rights sold32.92%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL3200049

Beneficial owner

Basilea Pharmaceutica AG

Declared address

Basilea Pharmaceutica AG, 4058 Basel

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG, Allschwil05.03.2021TAL3200049

Disclosure summary

Basilea Pharmaceutica AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the disposal side, published by SIX Exchange Regulation on 05.03.2021, at 32.92% of voting rights. Notice category: Single shareholder.

Disclosed position

32.92%

Voting rights sold

Voting rights acquired8.72%

Voting rights sold32.92%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Basilea Pharmaceutica AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 05.03.2021.

Publication date05.03.2021

Transaction date01.03.2021

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerBasilea Pharmaceutica AG

Declared addressBasilea Pharmaceutica AG, 4058 Basel

CategorySingle shareholder

Voting rights acquired8.72%

Voting rights sold32.92%

Below threshold0%

ExchangeXSWX

Notification IDTAL3200049

Commercial register

CHE-101.175.068

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 05.03.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open